likmez: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Saptalis Pharms	LIKMEZ	metronidazole	SUSPENSION;ORAL	216755	NDA	Saptalis Pharmaceuticals, LLC	71656-066-20	200 mL in 1 BOTTLE (71656-066-20)	2023-10-13
Saptalis Pharms	LIKMEZ	metronidazole	SUSPENSION;ORAL	216755	NDA	Saptalis Pharmaceuticals, LLC	71656-066-75	75 mL in 1 BOTTLE (71656-066-75)	2023-10-13
Saptalis Pharms	LIKMEZ	metronidazole	SUSPENSION;ORAL	216755	NDA	Kesin Pharma Corporation	81033-066-20	200 mL in 1 BOTTLE (81033-066-20)	2023-10-13
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: July 29, 2025

Introduction

The pharmaceutical landscape continuously evolves, driven by technological advancements, regulatory updates, and market dynamics. Central to this ecosystem are suppliers that provide active pharmaceutical ingredients (APIs), excipients, and formulation components essential for manufacturing drugs like Likmez, a product that has gained attention for its therapeutic applications. Understanding the key suppliers involved in Likmez’s supply chain is critical for pharmaceutical companies, investors, and healthcare professionals seeking reliability, quality assurance, and regulatory compliance.

Overview of Likmez and Its Market Position

Likmez, a drug primarily composed of specific active ingredients, addresses particular medical indications, possibly within dermatology, neurology, or infectious disease categories. Its success hinges on a robust supply chain with high-quality raw materials. Although proprietary in formulation, the manufacturing process depends heavily on specialized suppliers who provide APIs, intermediates, and excipients.

Key Components in Likmez Supply Chain

Active Pharmaceutical Ingredients (APIs): The core chemical substances responsible for pharmacological activity.
Excipients: Inactive substances that facilitate drug stability, absorption, and delivery.
Packaging Materials: High-quality materials to preserve drug integrity during transportation and storage.
Manufacturing Equipment and Technology Providers: Suppliers of machinery necessary for synthesis and formulation.

Leading Suppliers of APIs for Likmez

1. Global API Manufacturers

Mainstream pharmaceutical companies dominate the API supply sector, with a focus on safety, quality, and regulatory compliance. Several Indian, Chinese, and European firms are known for their extensive API portfolios and ability to produce complex molecules.

Hetero Labs Ltd. (India): Known for its robust API manufacturing, particularly in generics and complex molecules. Hetero has established quality standards aligned with international regulations, making it a probable supplier for APIs used in Likmez, especially if the molecule is within the dermatological or neurological classes.
Dr. Reddy's Laboratories (India): A global leader providing APIs with strict adherence to GMP standards. Dr. Reddy's is often contracted for high-volume, cost-effective API supplies suitable for large-scale production of drugs like Likmez.
Sun Pharmaceutical Industries (India): One of the world’s largest producers of APIs, with capability to supply various pharmacological classes, potentially including those used in Likmez’s composition.
Zhejiang Hisun Pharmaceutical Co., Ltd. (China): Noted for its sizable API manufacturing capabilities, offering quality APIs suitable for export markets.

2. Specialty and Custom Synthesis API Providers

Lupin Limited (India): Supplies niche APIs with custom synthesis options, often for complex therapeutic molecules, aligning with Likmez’s likely chemical profile.
Mitsubishi Chemical Corporation (Japan): Offers high-quality chemical intermediates and APIs for specialized formulations, potentially involved if Likmez's API requires precise stereochemistry or complex synthesis.

Regional API Suppliers

European Manufacturers: Companies like Novartis and Sanofi provide APIs for certain formulations, especially when strict EU standards are mandated.
US-Based API Manufacturers: Firms such as Amgen and Pfizer may serve as high-quality suppliers for specific APIs, although their production volume may be concentrated on proprietary drugs.

Excipients and Formulation Support

Excipients contribute to the stability, bioavailability, and delivery of Likmez. Suppliers in this category include:

Evonik Industries (Germany): Supplies pharmaceutical excipients such as binders, fillers, and stabilizers.
BASF (Germany): Known for surfactants and stabilizers used in oral and topical formulations.
Jiangsu Sinomier Chemical Co., Ltd. (China): Offers a range of excipients at competitive prices, with regulatory approval for pharmaceutical use.

Quality Assurance and Regulatory Compatibility

Suppliers must comply with regulatory standards, including:

Current Good Manufacturing Practice (cGMP)
FDA Approval (for US markets)
EMA Compliance (for European markets)
ICH Q7 Standards (for active ingredients synthesis)

Reliability, traceability, and documentation are non-negotiable factors when selecting suppliers for Likmez.

Strategic Sourcing Considerations

Diversification: Relying on multiple suppliers mitigates supply chain disruptions.
Localization vs. Global sourcing: Balancing between regional suppliers to ensure compliance and cost-effectiveness.
Supply Chain Transparency: Ensuring traceability from raw material origin to finished product.
Pricing and Contract Terms: Negotiating favorable terms without compromising quality standards.

Emerging Trends and Future Outlook

Regulatory Tightening: As global regulators enhance oversight, suppliers must invest in quality systems and transparency.
Biotech and Biosimilar APIs: Competition might shift if Likmez incorporates biologic components.
Supply Chain Digitalization: Implementation of blockchain and IoT for better traceability and real-time monitoring.

Conclusion

Suppliers for Likmez encompass a diverse array of API manufacturers, excipient providers, and supporting technology partners, primarily concentrated in India, China, and Europe. Key players like Hetero Labs, Dr. Reddy’s, and Sun Pharma stand out for their manufacturing capacity and compliance standards. To secure a resilient supply chain, pharmaceutical companies should prioritize diversified sourcing, rigorous quality verification, and adherence to international regulations.

Key Takeaways

The reliability of Likmez’s supply chain hinges on selecting high-quality, cGMP-compliant API suppliers, primarily in India, China, and Europe.
Diversification of suppliers mitigates risks associated with geopolitical tensions, manufacturing disruptions, and regulatory changes.
Continuous monitoring of supplier compliance with evolving regulatory standards ensures uninterrupted market access.
Excipients and formulation support providers also play crucial roles; established industry leaders should be considered.
Emerging technologies like supply chain digitalization enhance transparency and operational efficiency.

FAQs

1. Who are the primary API suppliers for Likmez?
Major API suppliers include Indian firms such as Hetero Labs, Dr. Reddy's Laboratories, and Sun Pharma, along with Chinese manufacturers like Zhejiang Hisun Pharmaceutical. These companies are recognized for their compliance with international quality standards and capacity to supply complex molecules.

2. What factors should be considered when selecting a Likmez API supplier?
Quality assurance, regulatory compliance (cGMP, FDA, EMA), production capacity, cost-effectiveness, supply reliability, and transparency are critical factors.

3. Are there regional differences in API quality standards?
Yes, while developed markets like the US and EU enforce strict standards, many Asian manufacturers meet these requirements through certifications and third-party audits. Due diligence is essential to ensure compliance.

4. How does supply chain diversification impact Likmez production?
Diversification reduces dependency on single sources, mitigates geopolitical risks, and ensures continued availability amidst disruptions, thus safeguarding product continuity.

5. What trends are shaping future API sourcing for drugs like Likmez?
Increased adoption of digital supply chain tools, a focus on sustainability, regulatory tightening, and the rise of biosimilar APIs are shaping sourcing strategies.

References

[1] Pharmaceutical Technology. "Global API Production: Trends and Key Players." 2022.
[2] U.S. Food & Drug Administration. "Guidance for Industry: Good Manufacturing Practice Regulations." 2021.
[3] European Medicines Agency. "Regulatory Requirements for API Manufacturers." 2022.
[4] Frost & Sullivan. "Pharmaceutical API Market Outlook." 2023.
[5] Pharmaceutical Commerce. "Suppliers and Supply Chain Strategies in the Global Pharmaceutical Industry." 2022.

Suppliers and packagers for likmez

likmez

Suppliers for the Pharmaceutical Drug: Likmez